RecruitingNCT06104280
Opioid treatment medications, sleep and body-clock rhythms
About this title
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment
Read the official source — NCT06104280Observational studyAges 18–80United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 80 years.
What will I do during this study?
This observational study does not assign your opioid-use medication. It compares groups taking methadone, buprenorphine or extended-release naltrexone with non-opioid-using controls. Study activities include pupil-response testing and two nights of sleep monitoring; relapse is followed for six months.
- Listed locations
- BirminghamSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 6, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 200
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Behavioural, Device, Other
- Locations
- United States
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT06104280
- Official title
Show the full official title
Medications for Opioid Use Disorder Differentially Modulate Intrinsically Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment (MOUD)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Birmingham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Alabama at Birmingham, a university.
Who can participate?
Listed age limits: 18 years to 80 years.
Is this study still recruiting?
The registry lists this study as recruiting.
